MRIQA extends traditional phantom QA by combining phantom validation with real patient-series quality analytics — detecting hidden scanner drift, protocol inefficiencies, and image artifacts before they affect clinical quality.
A single-scanner pilot on the GE Signa HDxt 1.5T revealed measurable quality gaps invisible to standard phantom testing.
Kruskal-Wallis: H = 21.60, p = 0.0006, η² = 0.177. Significant image-quality differences across sequence types — invisible to phantom QA.
Clinical series showed ghosting artifacts 69× higher than ACR phantom results on the same scanner.
PIU dropped below the ACR 87.5% threshold in clinical series while phantom QA continued to pass.
Prioritized HIGH / MEDIUM / LOW across all series. Protocol-specific, not generic.


ACR phantom QA validates scanner performance under controlled conditions — not real clinical variability.
Scanner performance degrades gradually between phantom QA cycles, going undetected until it affects patient images or triggers a failed accreditation.
Phantom QA uses fixed protocols that may not reflect the clinical sequences actually used on patients.
Phantoms test one controlled scenario and cannot capture the variable anatomy, motion, and positioning of real patients.
Individual coil elements and RF channels can silently underperform on patient scans even when phantom QA passes.
MRIQA adds the continuous, patient-specific layer that phantom testing cannot provide.
Three integrated modules deliver continuous MRI quality intelligence from phantom validation to patient-series analytics and prioritized recommendations.
MRIQA benchmarks image quality by sequence type, enabling protocol-specific optimization instead of generic pass/fail QA. Each sequence is benchmarked against sequence-specific quality baselines.
T1-weighted
T2-weighted
FLAIR
DWI (Diffusion-Weighted)
SWI (Susceptibility-Weighted)
Additional sequences auto-classified
MRIQA supports the full MRI quality ecosystem — from physicists to radiology leadership.
Automate ACR metric extraction, track longitudinal trends, and generate accreditation-ready reports with physicist sign-off built in.
Monitor fleet-wide scanner performance from a single dashboard, identify protocol inconsistencies, and reduce repeat scans.
Maintain continuous, audit-ready documentation of scanner performance and corrective actions between ACR accreditation cycles.
Detect early hardware degradation signals — coil performance, channel dropout, SNR trends — before they escalate to service events.
From a single-scanner pilot to enterprise-wide deployment — with full physicist support.
Start with one MRI system. Validate phantom QA automation, patient series analysis, and recommendations before broader rollout.
Unified fleet dashboard across all MRI systems. Cross-scanner trending and department-level accreditation documentation.
Centralized quality oversight across imaging sites. Standardized protocols and system-level reporting across vendors and field strengths.
All deployments supported by qualified medical physicists. Implementation support, protocol review, and ongoing QA consultation.
MRIQA delivers measurable impact across quality, operations, and cost — without disrupting existing workflows.
Detect scanner drift early
Reduce repeat scans
Maintain accreditation readiness
Reduce downtime
Improve scanner utilization
Lower repeat imaging costs
Monitor ACR accreditation status, QA pass/fail results, next QA due dates, and longitudinal PIU trends across your entire scanner fleet — in a single view. Status indicators (Pass / Action / Overdue) surface issues before they become compliance failures.

Fleet-wide scanner status: Pass / Action / Overdue
ACR accreditation countdown and renewal alerts
Next QA due dates per scanner
Longitudinal PIU trend tracking
One-click drill-down to individual scanner reports
Multi-vendor support: GE · Siemens · Philips (roadmap)
Every de-identified clinical DICOM series is automatically scored across five image quality dimensions: SNR, CNR, ghosting, sharpness, and motion. The batch overview surfaces studies needing attention — with per-study drill-down for root-cause analysis.

7 studies shown — dates, sequences, overall scores, grades
Grades: Suboptimal / Acceptable / Good / Excellent
Days-to-ACR-QA countdown per study
Scanner and session filtering
Sortable by score, grade, or date

Overall score: 33/100 — RED (Suboptimal)
Brain SNR: 4.3 — RED
GM CNR: 1.8 — RED
Ghosting: 8.9% — AMBER (single-study example; pilot mean: 3.82%)
Sharpness: 19.2 — RED
Motion Score: 6.3% — GREEN
Bar chart visualization of all five metrics
Nearest ACR QA date shown for context
Every analysis generates protocol-specific recommendations — automatically prioritized as HIGH, MEDIUM, or LOW.

Immediate action recommended. Issues with direct impact on diagnostic image quality or ACR compliance.
Action recommended within the next QA cycle. Performance is suboptimal but not immediately critical.
Monitor and address during routine maintenance. Optimization opportunities with lower urgency.
MRIQA is built for healthcare environments where patient privacy is non-negotiable.
All DICOM data is de-identified prior to analysis to minimize PHI handling within institutional workflows.
MRIQA analyzes image quality metrics — SNR, CNR, ghosting, motion — from pixel analysis and DICOM metadata, with no diagnostic interpretation.
Data governance, access controls, and audit logging are built into the platform architecture for seamless hospital IT and PACS integration.
MRIQA is designed to operate within institutional de-identification and governance workflows. HIPAA compliance depends on site-specific implementation. No protected health information is required for core quality analytics when de-identification workflows are followed. Role-based access controls, audit logs, and site-governed data retention policies are supported at deployment.
MRIQA is grounded in peer-reviewed methodology and original clinical research. The platform's analytical framework is documented in a technical white paper and supported by statistically validated pilot findings.
Peer-reviewed framework + pilot-validated analytics
MRIQA: Integrated Phantom and Patient-Specific MRI Quality Assurance for Diagnostic Imaging Optimization and ACR Accreditation Support.
Ali Fatemi, PhD, MCCPM, DABMP · June 2026
MRIQA's integrated phantom + patient-specific longitudinal QA architecture is patent pending.
Patent application filed. Details available under NDA to qualified partners.
Kruskal-Wallis analysis across six sequence groups: H = 21.60, p = 0.0006, η² = 0.177 — statistically significant image-quality differences across sequence types, invisible to standard phantom QA.
Analysis conducted on de-identified pilot data. Results are for research and quality optimization purposes only.
Ali Fatemi is a board-certified medical physicist specializing in MRI quality assurance, ACR accreditation, and clinical imaging optimization. MRIQA was built directly from clinical QA practice and validated on real-world patient data. Currently validating MRIQA across clinical MRI systems for quality optimization and accreditation support.
Email: contact@spintecx.com
Continuous MRI quality intelligence beyond phantom QA.
MRIQA is a scanner quality optimization platform for QA and accreditation support. Not for diagnostic use.
© 2026 MRIQA LLC | MRI Quality Intelligence · contact@spintecx.com
Continuous MRI Quality Intelligence